Also, again why it's important to exercise caution, a small randomised control trial of remdesmivir in China just showed the improvements were not clinically significant.
Larger trials need to be done. And these trials were using much larger numbers than the remestemcell data that drove this SP through the roof, and we still don't know if remdesmivir is useful.
Who knows what will come of this. Exciting times.
Be careful and DYOR
MSB Trading - 2020, page-6876
-
- There are more pages in this discussion • 16,285 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |